本文選題：中心性漿液性脈絡(luò)膜視網(wǎng)膜病變 + 五苓散�。� 參考：《南京中醫(yī)藥大學(xué)學(xué)報》2017年03期

【摘要】：目的觀察五苓散加減辨證治療中心性漿液性脈絡(luò)膜視網(wǎng)膜病變(CSC)的臨床療效。方法將60例CSC患者隨機分為治療組及對照組各30例。治療組口服五苓散加減方治療,對照組口服維生素B1、維生素C治療。2組均以1月為1個療程,治療3個療程后觀察臨床療效。結(jié)果治療組總有效率為96.7%,對照組總有效率為73.3%,治療組療效優(yōu)于對照組(P0.05);2組治療前后視力、FFA熒光滲漏面積及水腫程度比較,P0.01,治療組優(yōu)于對照組(P0.05)。結(jié)論五苓散加減方治療CSC有良好療效。
[Abstract]:Objective to observe the clinical effect of Wulingsan plus subtraction in the treatment of central serous chorioretinopathy (CSCS). Methods 60 patients with CSC were randomly divided into treatment group (n = 30) and control group (n = 30). The treatment group was treated with Wulingsan plus and subtractive prescription, the control group was treated with vitamin B1 and vitamin C for one month, and the clinical effect was observed after three courses of treatment. Results the total effective rate of the treatment group was 96.7g and the total effective rate of the control group was 73.3. The curative effect of the treatment group was better than that of the control group (P 0.05). The area of fluorescence leakage and the degree of edema of FFA in the treatment group were better than that in the control group (P 0.01), and that in the treatment group was better than that in the control group (P 0.05). Conclusion Wuling Powder plus or minus prescription has good curative effect on CSC.
【作者單位】： 浙江中醫(yī)藥大學(xué)附屬第三醫(yī)院;
【分類號】：R276.7

【相似文獻】

相關(guān)期刊論文 前10條

1 張苗海;五苓散治療以恐懼為主要表現(xiàn)的焦慮癥1例[J];國外醫(yī)學(xué)(中醫(yī)中藥分冊);2005年04期

2 孫太安;許志堅;梁書君;;五苓散治療膝關(guān)節(jié)創(chuàng)傷性滑膜炎66例[J];中國社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè)半月刊);2008年20期

3 蔣改蘇;五苓散治脫發(fā)1例[J];天津中醫(yī);1995年03期

4 李晨;五苓散治療產(chǎn)后尿潴留[J];中國民間療法;2002年11期

5 鄒風(fēng)華,張東軍;五苓散為主治療早期腎功能不全20例[J];中醫(yī)藥信息;2002年01期

6 王立群;王儉運用五苓散治療眩暈經(jīng)驗拾零[J];甘肅中醫(yī);2004年09期

7 楊華;王愛萍;;五苓散在兒科的臨床應(yīng)用[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2006年06期

8 駱玲華;;五苓散兒科新用舉隅[J];中國民間療法;2006年08期

9 李春娟;金東明;;五苓散治療代謝性高血壓的實驗研究[J];吉林中醫(yī)藥;2008年02期

10 謝e，

本文編號：1836158